Elevation Oncology, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Elevation Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Elevation Oncology, Inc. Return On Equity for the quarter ending September 30, 2024 was -59.7 %, a 42.9% increase year-over-year.
  • Elevation Oncology, Inc. annual Return On Equity for 2023 was -81.9 %, a 25.8% increase from 2022.
  • Elevation Oncology, Inc. annual Return On Equity for 2022 was -110 %, a 259% decline from 2021.
  • Elevation Oncology, Inc. annual Return On Equity for 2021 was -30.7 %, a 125% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -59.7 +44.9 +42.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -58 +95.2 +62.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -59.4 +89.7 +60.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -81.9 +28.4 +25.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -105 -26.1 -33.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -153 -108 -236% Apr 1, 2023 Jun 30, 2023
Q1 2023 -149 -118 -380% Jan 1, 2023 Mar 31, 2023
Q4 2022 -110 -79.6 -259% Oct 1, 2022 Dec 31, 2022
Q3 2022 -78.5 Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.6 Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -30.7 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.